tirzepatide for diabetes appears to be more effective than standard care in early type 2 FDA approval for Zepbound (tirzepatide)

Reduced metabotropic glutamate receptor 5 density in major depression determined by [ 11 C]ABP688 PET and postmortem study

But the gap between "berberine has some evidence when swallowed at 1,500 mg" and "a patch with 8.75 mg of berberine will help you lose weight through your skin" is a canyon, and the marketing fills that canyon with aspiration rather than data

Autism-like behaviours (33%) were reported in a study of 49 individuals with KAT6A mutations (St John et al, 2022)

The details ( Evidence, limitations, Mechanisms and massage for patients) in first 4 comments What this means for users/patients +If someone is being treated with semaglutide and has risk factors for optic nerve issues (for example: previous NAION in one eye, glaucoma, optic disc crowding, severe diabetic retinopathy, major vascular disease), then this potential risk should be discussed with their ophthalmologist and prescribing physician

27 Approximately 3%-13% of acute pancreatitis cases develop into chronic pancreatitis